Does vascular disease cause late-life depression?

Economics of Neuroscience

Volumn 3, Issue 7, 2001, Pages 49-56

  Alexopoulos, G S ^a  

^a The Cornell Institute of Geriatric Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ACETYLCHOLINE; ACETYLSALICYLIC ACID; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; BROMOCRIPTINE; CALCIUM CHANNEL BLOCKING AGENT; DESIPRAMINE; DIPYRIDAMOLE; DOPAMINE; FIBRINOLYTIC AGENT; FLUOXETINE; HALOPERIDOL; HYPOCHOLESTEROLEMIC AGENT; IDAZOXAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NEUROTRANSMITTER; OPIATE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; STEROID; TICLOPIDINE; TRAZODONE; UNINDEXED DRUG; WARFARIN; YOHIMBINE;

AGED; ANIMAL EXPERIMENT; ARTICLE; AWARENESS; BEHAVIOR THERAPY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CORPUS STRIATUM; DEPRESSION; DISABILITY; DISEASE PREDISPOSITION; FRONTAL LOBE; GERONTOPSYCHIATRY; HEMODYNAMICS; HIPPOCAMPUS; HUMAN; HYPOTHESIS; IMAGING; LIMBIC CORTEX; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; RECURRENCE RISK; RELAPSE; SOCIAL PSYCHOLOGY;

EID: 0034884906     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (113)

1. Late-onset depression
2. Geriatric depression: Age of onset and dementia
3. The course of geriatric depression with "reversible dementia"
4. Brain computed tomography in geriatric depression and primary degenerative dementia
5. Computed tomography in the elderly. 3. Affective disorder
6. Leukoencephalopathy in elderly depressed patients referred for ECT
7. Affective disorders arising in the senium, ii. Physical disability as an etiological factor
8. Computed tomography and the outcome of affective disorder: A follow-up study of elderly subjects
9. Disability in geriatric depression
10. Age-of-onset and genetic transmission in affective disorders
11. Personality disorder correlates of late- and early-onset depression
12. Depression in late life: Age of onset as marker of a subtype
13. Age of onset in geriatric depression: Relationship to clinical variables
14. The effect of age of onset on depression in the elderly
15. The "vascular depression" hypothesis
16. Vascular depression: A new view of late-onset depression
17. Hypertension and DSM-III depression in psychiatric outpatients
18. Major depressive disorder in coronary artery disease
19. Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study
20. Gender depression, and one-year prognosis after myocardial infarction
21. Depression following myocardial infarction. Impact on 6-month survival
22. The nature and course of depression following myocardial infarction
23. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease
24. Depression in patients with coronary heart disease
25. Can treating depression reduce mortality after an acute myocardial infarction?
26. Depression and coronary heart disease: A review for cardiologists
27. New views on old age affective disorder
28. Depression in later life. A comparison of symptoms and risk factors in early and late onset cases
29. Diagnosis, treatment, comorbidity, and resource utilization in patients in a general medical practice
30. Cerebrovascular risk factors and depression in older primary care patients: Testing a vascular brain disease model of depression
31. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease?
32. Cerebrovascular risk factors and later life major depression. Testing a small-vessel brain disease model
33. Depression in cerebrovascular disease
34. Mood disorders as a specific complication of stroke
35. Affective illness after stroke
36. Neurobehavioral changes associated with caudate lesions
37. A method of using MR to evaluate the effects of cardiovascular disease on the brain: The Cardiovascular Health Study
38. Incidence of silent cerebral infarction in patients with major depression
39. Leukoencephalopathy in patients diagnosed as major depressive
40. Leukoencephalopathy in elderly depressed patients referred for ECT
41. Pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly
42. White matter signal abnormalities in normal individuals: Correlation with carotid ultrasonography, cerebral blood flow, measurements, and cerebrovascular risk factors
43. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects
44. Late-onset depression with white matter lesions
45. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression
46. Mood, vegetative disturbance, and dexamethasone suppression after stroke
47. Mood changes after right hemisphere lesions
48. A two year longitudinal study of post-stroke mood disorders: Dynamic changes in associated variables over the first six months of follow-up
49. Mood disorders after stroke and their relation to lesion location. A CT scan study
50. Differential mood changes following basal ganglia vs thalamic lesions
51. Subcortical hyperintensity on MRI: A comparison of normal and depressed elderly subjects
52. White matter hyperintensity on MRI: Clinical and neuroanatomic correlates in the depressed elderly
53. Quantitative cerebral anatomy in depression: A controlled magnetic resonance imaging study
54. Magnetic resonance imaging of the caudate nuclei in depression
55. A magnetic resonance imaging study of putamen nuclei in major depression
56. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
57. Glial reduction in the prefrontal cortex in mood disorders
58. Comparison of regional cerebral brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography
59. Regional cerebral blood flow in patients with refractory unipolar depression measured with Tc-99m HMPAO SPECT
60. Reduction of prefrontal cortex glucose metabolism common to three types of depression
61. The anatomy of melancholia. Focal abnormalities of cerebral blood flow in major depression
62. Paralimbic hypoperfusion in unipolar depression
63. A functional anatomical study of unipolar depression
64. Prefrontal cortical-amygdalar metabolism in major depression
65. Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders
66. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment
67. Neural correlates of self-induced dysphoria
68. Limbic-cortical dysregulation: A proposed model of depression
69. Prefrontal dysfunction in vascular depression
70. Reduction of cerebral blood flow in older depressed patients
71. Decreased cingulate and hippocampal activation in geriatric depression
72. Neuroanatomical substrates of depression in the elderly
73. Depression in Parkinson's disease: A biochemical and organic viewpoint
74. Late-life depression, vascular diseases, and brainstem evoked response abnormalities
75. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect
76. Brain imaging abnormalities in mental disorders of late life
77. Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects
78. Occult subcortical magnetic resonance imaging in elderly depressives
79. Major depression in stroke patients. A three year longitudinal study
80. The depression-executive dysfunction syndrome of late life: A target for D3 receptor agonists
81. Clinical presentation of the "depression-executive dysfunction syndrome" of late life
82. Prefrontal dysfunction and treatment response in geriatric depression
83. Executive dysfunction and risk for relapse and recurrence of geriatric depression
84. Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression
85. MRI-defined vascular depression
86. Clinically defined vascular depression
87. Cognition and white matter hyperintensities in older depressed adults
88. Cognitive impairment and major depression: Beyond the pseudodementia syndrome
89. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression
90. Depressive symptoms in Alzheimer's disease and multi-infarct dementia
91. White matter lesions in the elderly
92. Cerebrovascular risk factors and 1-year depression outcome in older primary care patients
93. Clinical and neuroradiologic features associated with chronicity in late-life depression
94. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological, and neuroradiological findings in late-life depression
95. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression
96. ECT and vascular depression
97. Microanatomy of treatment response of late life depression
98. Cingulate function in depression: A potential predictor of treatment response
99. The 3-year course and outcome of patients with major depression and silent cerebral infarction
100. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow up study
101. Effectiveness versus efficacy of treatment of hypertension for stroke prevention
102. Assessing the benefits of lipid-lowering therapy
103. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation Study II
104. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study
105. European Stroke Prevention Study: Antithrombotic therapy is also effective in the elderly
106. Aspirin for the primary prevention of stroke and other major vascular events
107. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients
108. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders
109. Pharmacologic modulation of recovery after stroke: Clinical data
110. Basic and clinical studies of pharmacologic effects on recovery from brain injury
111. Common drugs may influence motor recovery after stroke
112. Effects of fluoxetine and maprotilene on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy
113. Late life depression and functional disability: The role of goal-focused group psychotherapy